Matrix Metalloproteinase System Deficiencies and Matrix Degradation
- 1 January 1999
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 82 (08) , 837-845
- https://doi.org/10.1055/s-0037-1615920
Abstract
Matrix metalloproteinases (MMPs) constitute a tightly regulated family of enzymes that degrade most components of the extracellular matrix. They are classified based on substrate specificity. Collagenases (MMP-1, interstitial collagenase, EC 3.4.24.7; MMP-8, neutrophil collagenase, EC 3.4.24.34; MMP-13, collagenase-3) degrade connective tissue collagens. Gelatinases (MMP-2, gelatinase A, EC 3.4.24.24; MMP-9, gelatinase B, EC 3.4.24.35) degrade collagen types IV, V, VII and X, elastin, and denatured collagens. Stromelysins (MMP-3, stromelysin-1, EC 3.4.24.17; MMP-10, stromelysin-2, EC 3.4.24.22) and matrilysin (MMP-7, EC 3.4.24.23) degrade the proteoglycan core proteins, laminin, fibronectin, elastin, gelatin, and nonhelical collagen, whereas stromelysin-3 (MMP-11) does not degrade any of the major extracellular matrix components. Macrophage metalloelastase (MMP-12, EC 3.4.24.65) degrades insoluble elastin, collagen IV, fibronectin, laminin, entactin, and proteoglycans.1-7 About 20 members of the MMP family have been identified, including at least four membrane-type (MT) MMPs.8-13 MMPs are generally secreted as zymogens that are extracellularly activated by organomercurial compounds, several proteinases (including plasmin, trypsin, chymotrypsin, kallikrein, cathepsin G, or neutrophil elastase), oxygen free radicals, or by association with the cell surface.1,5,6 Active MMPs are inhibited by specific tissue inhibitors of MMPs (TIMPs) via formation of a noncovalent stoichiometric complex.5,6 Four members of the TIMP family have been identified, of which TIMP-1, synthesized by most types of connective tissue cells and by macrophages, acts against all members of the collagenase, stromelysin, and gelatinase classes.2,14,15 MMPs are mainly involved in the degradation of extracellular matrix components, but may also play a role in activation and processing of cytokines or growth factors,16 in shedding of membrane-bound receptors,17 in liberation of Fas ligand,18 or in activation of tumor necrosis factor-α.19 Degradation of extracellular matrix is required to allow cell migration and tissue remodeling, which play essential roles in many (patho)physiological processes. The role of the plasminogen/plasmin (fibrinolytic) and MMP systems in neointima formation after vascular injury, atherosclerosis, graft arterial disease, myocardial ischemia, angiogenesis, tumor growth and dissemination, infection, and chronic inflammatory disorders of the kidney, lung, gastrointestinal tract, skin, joints, or cornea has recently been reviewed.20 We will discuss some recent data on interactions between the MMP and plasminogen/plasmin systems and their role in neointima formation and atherosclerotic aneurysm formation.Keywords
This publication has 72 references indexed in Scilit:
- Matrix Metalloproteinase MMP-19 (RASI-1) is Expressed on the Surface of Activated Peripheral Blood Mononuclear Cells and is Detected as an Autoantigen in Rheumatoid ArthritisImmunobiology, 1998
- Increased Expression of Membrane-Type Matrix Metalloproteinase and Preferential Localization of Matrix Metalloproteinase-2 to the Neointima of Balloon-Injured Rat Carotid ArteriesCirculation, 1998
- The Matrix Metalloproteinase-14 (MMP-14) Gene Is Structurally Distinct from Other MMP Genes and Is Co-expressed with the TIMP-2 Gene during Mouse EmbryogenesisPublished by Elsevier ,1997
- Membrane-Type Matrix Metalloproteinases (MT-MMPs) in Cell InvasionThrombosis and Haemostasis, 1997
- Genes of the Membrane-Type Matrix Metalloproteinase (MT-MMP) Gene Family, MMP14, MMP15, and MMP16, Localize to Human Chromosomes 14, 16, and 8, RespectivelyGenomics, 1997
- Murine tissue inhibitor of metalloproteinases—4 (Timp—4): cDNA isolation and expression in adult mouse tissues1FEBS Letters, 1997
- Plasminogen Activators and Matrix Metalloproteinases in AngiogenesisEnzyme and Protein, 1996
- Matrix Metalloproteinases and Cardiovascular DiseaseCirculation Research, 1995
- Proteolytic remodeling of extracellular matrixCurrent Opinion in Cell Biology, 1995
- Metalloproteinases and their inhibitors in matrix remodelingTrends in Genetics, 1990